Abbott Laboratories forward PE ABT

Share price divided by analysts' consensus earnings for the next twelve months, since 1993.

Today, Oct 23, 2026: 17.7×
10-year median: 23.8×
Against its 10-year history: 7th; percentile: 0 is its lowest day, 100 its highest
10-year range: 15.0× to 31.4×
Peer median: 17.6×

Abbott Laboratories' forward PE is 17.7× as of Oct 23, 2026.

That is below its ten-year median of 23.8×, lower than on 93% of days in the last ten years.

Over that time it ranged from 15.0× in May 2026 to 31.4× in Jul 2019.

The median for 7 medical device stocks of a similar size is 17.6×.

Forward PE over time

median 23.8×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	17.7×	15.0×	23.6×
2025	23.4×	22.6×	26.9×
2024	23.1×	20.9×	26.3×
2023	24.7×	20.9×	27.9×
2022	27.0×	23.4×	30.0×
2021	29.7×	23.6×	29.7×
2020	23.9×	20.8×	31.1×
2019	30.5×	22.2×	31.4×
2018	23.2×	20.3×	24.7×
2017	20.9×	17.1×	21.0×
2016	16.9×	16.7×	20.9×
2015	21.9×	20.4×	25.5×
2014	22.7×	18.3×	22.8×
2013	19.9×	11.8×	21.2×
2012	7.4×	5.3×	7.7×
2011	5.5×	4.8×	5.5×
2010	5.2×	5.1×	6.7×
2009	6.5×	5.3×	7.6×
2008	7.2×	6.9×	9.6×
2007	9.1×	8.2×	10.3×

Against its peers

Companies in Medical - Devices nearest Abbott Laboratories' size, closest first, today.

Company	Forward PE
ABTAbbott Laboratories	17.7×
MDTMedtronic	15.9×
SYKStryker	19.3×
BSXBoston Scientific	14.1×
EWEdwards Lifesciences	28.3×
GEHCGE HealthCare Technologies	13.8×
DXCMDexCom	27.7×
ZBHZimmer Biomet	n/m
Peer median	17.6×

Where Abbott Laboratories ranks

#21of 51Healthcare stocks with the lowest forward PE

What the forward PE tells you

Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.

Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.

More on Abbott Laboratories

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.